This article was originally published in The Gray Sheet
Surgical cryoablation system will debut in July following recent 510(k) clearance received by strategic partner Endocare for treatment of cardiac arrhythmias in patients undergoing other cardiac procedures such as bypass surgery and valve replacement. The firm sees a $200 mil. market opportunity...
You may also be interested in...
CryoCath aims to place its Freezor cryoablation catheter in 300 centers by year-end, pending PMA approval of the supraventricular tachycardia treatment device
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.